Credit Suisse’s MediciNova MNOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,200
Closed -$3K 4066
2022
Q3
$3K Buy
1,200
+200
+20% +$463 ﹤0.01% 3675
2022
Q2
$3K Buy
+1,000
New +$2.61K ﹤0.01% 3772
2021
Q1
Sell
-12,226
Closed -$65K 4462
2020
Q4
$65K Buy
+12,226
New +$70.1K ﹤0.01% 4222
2019
Q4
Sell
-43,405
Closed -$346K 4270
2019
Q3
$346K Buy
43,405
+31,537
+266% +$281K ﹤0.01% 3631
2019
Q2
$114K Buy
11,868
+734
+7% +$7.74K ﹤0.01% 3938
2019
Q1
$92K Buy
11,134
+812
+8% +$7.08K ﹤0.01% 3857
2018
Q4
$85K Buy
+10,322
New +$103K ﹤0.01% 3772
2018
Q3
Sell
-15,317
Closed -$122K 3910
2018
Q2
$122K Sell
15,317
-21,820
-59% -$226K ﹤0.01% 3818
2018
Q1
$380K Buy
37,137
+26,794
+259% +$267K ﹤0.01% 3488
2017
Q4
$67K Sell
10,343
-15,606
-60% -$104K ﹤0.01% 3888
2017
Q3
$165K Sell
25,949
-6,559
-20% -$34.9K ﹤0.01% 3984
2017
Q2
$172K Buy
+32,508
New +$182K ﹤0.01% 3648
2017
Q1
Sell
-42,407
Closed -$256K 3971
2016
Q4
$256K Buy
42,407
+30,381
+253% +$214K ﹤0.01% 3722
2016
Q3
$90K Sell
12,026
-1,790
-13% -$12.1K ﹤0.01% 3946
2016
Q2
$104K Sell
13,816
-20,349
-60% -$147K ﹤0.01% 4052
2016
Q1
$250K Buy
+34,165
New +$169K ﹤0.01% 3592

Other funds holding MNOV

Credit Suisse's MNOV Position: Q4 2022 in Review

Credit Suisse sold out of MediciNova (MNOV) in Q4 2022, closing a stake of 1,200 shares — an estimated $3K sold.

Credit Suisse first reported a position in MNOV in Q1 2016 and held it in 16 quarters. The position peaked at $380K in Q1 2018. 41 funds tracked by Wall St. Rank hold MNOV as of Q4 2022.

  • Credit Suisse reported no remaining MediciNova position as of Q4 2022 after selling out during the quarter.
  • Credit Suisse sold 1,200 MediciNova shares in Q4 2022, an estimated $3K.
  • Credit Suisse first reported a position in MediciNova in Q1 2016 and held it in 16 quarters.
  • Credit Suisse's MediciNova position peaked at $380K in Q1 2018.
  • 41 funds tracked by Wall St. Rank held MediciNova as of Q4 2022.

Based on Credit Suisse's 13F filing for Q4 2022, filed 13 Feb 2023.